Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia

J Antimicrob Chemother. 2013 Jun;68(6):1445-7. doi: 10.1093/jac/dkt017. Epub 2013 Feb 6.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Australia
  • Ceftriaxone / therapeutic use*
  • Gonorrhea / drug therapy*
  • Gonorrhea / microbiology
  • Homosexuality, Male
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Pharyngeal Diseases / drug therapy*
  • Pharyngeal Diseases / microbiology
  • Pharynx / microbiology
  • Rectum / microbiology
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone